The effects of inhibiting monoamine oxidase (MAO) A and B on metabolism and uptake of serotonin (5-HT) in serotonergic synaptosomes were studied. To avoid contamination by extrasynaptosomal MAO, synaptosomes were separated from other components of rat brains by discontinuous sucrose density gradient centrifugation. Kinetic analysis of 5-HT uptake demonstrated that 5-HT was selectively transported into serotonergic synaptosomes through the high affinity 5-HT uptake process. Selectivity of the uptake and subsequent deamination of 5-HT within serotonergic synaptosomes were confirmed using selective and non-selective 5-HT and norepinephrine (NE) uptake inhibitors. MAO inhibitor analysis of 5-HT deamination occurring within serotonergic synaptosomes indicated that, at physiologically relevant concentrations of 5-HT, MAO A deaminates 5-HT, maintaining a low cytoplasmic concentration of 5-HT. When the cytoplasmic concentration of 5-HT is increased above physiologically relevant levels by the inhibition of MAO A, MAO B becomes active. [ 14C] 5-HT uptake into synaptosomes was reduced by decreasing the V max of [14C] 5-HT uptake. One mechanism for a decrease in the Vmax could be the increase in the cytoplasmic concentration of 5-HT.
Blier P., De Montigny C. (1987) Antidepressant monoamine oxidase inhibitors enhance serotonin but not norepinephrine neurotransmission. In Dahl S G, Gram L F, Paul S M, Potter W G (eds), Clinical pharmacology in psychiatry. Springer-Verlag , Berlin, pp. 127-134
2.
Brody T.M., Bain J.A. (1952) A mitochondria preparation from mammalian brain . J Biol Chem195: 685-690
3.
Denney R.M., Denney C.B. (1985) An update of the identity crisis of monoamine oxidase: new and old evidence for the independence of MAO A and B. Pharmacol Ther30: 227-259
4.
Fagervall I., Ross S.B. (1986) A and B forms of monoamine oxidase within the monoaminergic neurons of rat brain. J Neurochem47: 569-576
5.
Fowler C.J., Tipton K.F. (1982) Deamination of 5-hydroxytryptamine by both forms of monoamine oxidase by the rat brain. J Neurochem38: 733-736
6.
Graham D., Tahraoui L., Langer S.Z. (1987) Effect of chronic treatment with selective monoamine oxidase inhibitors and specific 5-hydroxytryptamine uptake inhibitors on 3H paroxetine binding to cerebral cortical membranes of the rat . Neuropharmacology26: 1087-1092
7.
Gray E.G., Whittaker V.P. (1962) Isolation of nerve ending from the C.N.S.: An electron microscopic study of cell fragments derived by homogenization and centrifugation . J Anat96: 79-87
8.
Green A.R., Youdim M B H (1975) Effect of monoamine oxidase inhibition by clorgyline, L-deprenyl and tranylcypromine on 5-hydroxytryptamine concentration in rat brain and hyperactivity following subsequent tryptophan administration. Br J Pharmacol55: 415-422
9.
Habert E., Graham D., Tahraoui L., Claustre Y., Langer S.Z. (1985) Characterization of 3H proxetine binding to rat cortical membranes. Eur J Pharmacol122: 197-204
10.
Hyttel J. (1978) Effect of a specific 5-HT uptake inhibitor, citalopram, (Lu 10-171), on 3H 5-HT uptake in rat brain synaptosomes in vitro . Biochem Pharmacol60: 13-18
11.
Kato T., Dong B., Ishii K., Kinemuchi H. (1986) Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats. J Neurochem46: 1277-1282
12.
Kishimoto S., Kimura H., Maeda T. (1983) Histochemical demonstration for monoamine oxidase (MAO) by a new coupled peroxidation method. Cell Mol Biol29: 61-69
13.
Kitahama K., Arai R., Maeda T., Jouvet M. (1986) Demonstration of monoamine oxidase type B in serotonergic and type A in noradrenergic neurons in the cat dorsal pontine tegmentum by an improved histochemical technique. Neurosci Lett71: 19-24
14.
Lai J C K, Leung T K C, Guest J.F., Lim G.L., Davison A.N. (1983) The monoamine oxidase inhibitors dorgyline and L-deprenyl also affect the uptake of dopamine, noradrenaline and serotonin by brain synaptosomal preparation. Biochem Pharmacol29: 2763-2767
15.
Levitt P., Pintar J.E., Breakefield X.O. (1982) Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons. Proc Natl Acad Sci USA79: 6385-6389
16.
Lineweaver A., Burk D. ( 1934) The determination of enzyme dissociation constants . Am Chem Soc56: 658-666
17.
Lowry O., Rosenburg A.L., Randall R.J. (1951) Protein measurement with the Folin phenol reagent . J Biol Chem Soc193: 265-275
18.
Mellerup E.T., Plenge P., Nielsen M. (1985) Size determination of binding polymers for 3H paroxetine in human platelet membranes. Eur J Pharmacol106: 411-413
19.
Murphy D.L., Garrick N.A., Alulakh C.S., Cohen R.M. (1984) New contributions from basic science to understanding the effects of monoamine oxidase inhibiting antidepressants. J Clin Psychiatr45: 37-43
20.
Neff N.H., Fuentes J.A. (1976) Monoamine oxidase and its inhibition. CIBA Found Symp39: 163-179
21.
Richelson E., Pfenning M. (1984) Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: Most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol104: 277-286
22.
Ross S.B. (1980) Neuronal transport of 5-hydroxytryptamine. Pharmacology21: 123-131
23.
Ross S.B. (1982) The characteristics of serotonin uptake systems . In Osborne N N (ed.), Biology of serotonergic transmission. John Wiley & Sons, New York, pp. 159-195
24.
Ross S.B. (1987) Distribution of the two forms of monoamine oxidase within monoaminergic neurons of the guinea pig brain. J Neurochem48: 609-614
25.
Smith L.T., Hanson D.R., Omenn G.S. (1978) Comparisons of serotonin uptake by blood platelets and brain synaptosomes. Brain Res146: 400-403
26.
Strada S.J., Sulser F. (1972) Effect of monoamine oxidase inhibitors on metabolism and in vivo release of 3H norepinephrine from hypothalamus. Eur J Pharmacol18: 303-308
27.
Thorpe L.W., Westland R.K., Kochersperger L.M., Abell C.W., Denney R.M. (1987) Immunochemical localization of monoamine oxidase A and B in human peripheral tissues and brain. J Histochem Cytochem35: 23-32
28.
Trendelenburg U. (1989) The uptake and metabolism of 3H-catecholamines in rat cerebral cortex slices. Naunyn-Schmiedeberg's Arch Pharmacol339: 293-297
29.
Urwyler S., Von Wartburg J-P. (1982) Uptake and metabolism of catecholamines in rat brain synaptosomes: Studies on the contribution of monoamine oxidase. Biochem Pharmacol30: 2777-2785
30.
Wolf W.A., Youdim M B H, Kuhn D.M. (1985) Does brain 5-HIAA indicate serotonin release or monoamine oxidase activity? Eur J Pharmacol109: 381-387
31.
Wong D.T., Horng J-S., Fuller R.W. (1973) Kinetics of serotonin accumulation into synaptosomes of rat brain-effects of amphetamine and chloramphetamines. Biochem Pharmacol22: 311-322
32.
Yang H Y T, Neff N.H. (1974) The monoamine oxidases of brain selective inhibition with drugs and the consequences for the metabolism of the biogenic amines . J Pharmacol Exp Ther189: 733-740
33.
Ziance R.J., Moxley K., Mullis M., Gray W. ( 1977) Influence of MAO inhibitors on uptake and release of norepinephrine in rat brain in vitro. Arch Int Pharmacol228: 30-38
